Expand QURE Menu
QURE MENU

QURE Stock Posts


Unusual Option Volume

QURE Uniqure N.V. -23.43-1.40 (-5.6%)

Uniqure N.V. - trades 4,013 contracts. QURE will report earnings on Nov 4, 2026. The company has the following event: on Nov 2, 2026. News: uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the Treatment of Huntington's Disease
View Details...

QURE 24.38-14.73 (-37.7%)Uniqure N.V. -

  • ATM straddle for 16-Oct-26 expiration returned a positive 53.0% from the previous business day
  • The upside wing (25 delta calls) declined -98.6%
  • Downside put (25 delta puts) gained 258.9%
  • The company has the following event: Investor Conference Call and Webcast on Sep 29, 2026.
  • The option volume for 16-Oct-26 expiration is 19,467
  • News: QURE Investor Alert: uniQure Securities Investigation - Kehoe Law Firm, P.C.
Top Implied #Volatility Decliners QURE BEKE $SMMT
Unusual Option Volume

QURE Uniqure N.V. -25.81-13.30 (-34.0%)

Uniqure N.V. - trades 4,809 contracts. The company has the following event: Investor Conference Call and Webcast on Sep 29, 2026. News: uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington's Disease Showing Continued Slowing of Disease Progression
View Details...
QURE stock declines -58.6% in premarket,

Premarket Decliner

QURE Uniqure N.V. -39.11+0.88+2.3%

Premarket:16.19-22.92 (-58.6%)

uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington's Disease Showing Continued Slowing of Disease Progression

Globe NewswireTue, 29-Sep 7:12 AM
Unusual Option Volume

QURE Uniqure N.V. -38.80+0.57 (+1.5%)

Uniqure N.V. - trades 11,269 contracts.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes